Caplin FDA Wednesday, May 13, 2026 0.00 Neutral

FDA Approves FOSCARNET SODIUM — Caplin Steriles Limited

Caplin Steriles Limited has received FDA approval for its ANDA220068 application, granting it authorization to market foscarnet sodium injection in the United States. This approval positions the manufacturer to significantly strengthen domestic supply and competitively address the growing market demand for this critical treatment.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day